Global Metabolism Drugs Market Survey and Trend Research 2018

December 2017 | 91 pages | ID: G927DE0962BEN
99Strategy

Abstracts

SUMMARY

Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, KOWA, KOWA, Kythera, Fuji yakuhin, LG Life Science, Metsubishi Tanabe Pharma etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Metabolism Drugs Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 METABOLISM DRUGS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Merck (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Novartis (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Takeda Pharmaceutical (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Astra Zeneca (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 KOWA (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 KOWA (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Kythera (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Fuji yakuhin (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 LG Life Science (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Metsubishi Tanabe Pharma (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Metabolism Drugs Market 2012-2017, by Type, in USD Million
Table Global Metabolism Drugs Market 2012-2017, by Type, in Volume
Table Global Metabolism Drugs Market Forecast 2018-2023, by Type, in USD Million
Table Global Metabolism Drugs Market Forecast 2018-2023, by Type, in Volume
Table Merck Overview List
Table Metabolism Drugs Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Metabolism Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Overview List
Table Metabolism Drugs Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astra Zeneca Overview List
Table Metabolism Drugs Business Operation of Astra Zeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table KOWA Overview List
Table Metabolism Drugs Business Operation of KOWA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table KOWA Overview List
Table Metabolism Drugs Business Operation of KOWA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kythera Overview List
Table Metabolism Drugs Business Operation of Kythera (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fuji yakuhin Overview List
Table Metabolism Drugs Business Operation of Fuji yakuhin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table LG Life Science Overview List
Table Metabolism Drugs Business Operation of LG Life Science (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Metsubishi Tanabe Pharma Overview List
Table Metabolism Drugs Business Operation of Metsubishi Tanabe Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Metabolism Drugs Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Metabolism Drugs Sales Revenue Share, by Companies, in USD Million
Table Global Metabolism Drugs Sales Volume 2012-2017, by Companies, in Volume
Table Global Metabolism Drugs Sales Revenue Share, by Companies in 2017, in Volume
Table Metabolism Drugs Demand 2012-2017, by Application, in USD Million
Table Metabolism Drugs Demand 2012-2017, by Application, in Volume
Table Metabolism Drugs Demand Forecast 2018-2023, by Application, in USD Million
Table Metabolism Drugs Demand Forecast 2018-2023, by Application, in Volume
Table Global Metabolism Drugs Market 2012-2017, by Region, in USD Million
Table Global Metabolism Drugs Market 2012-2017, by Region, in Volume
Table Metabolism Drugs Market Forecast 2018-2023, by Region, in USD Million
Table Metabolism Drugs Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Metabolism Drugs Industry Chain Structure
Figure Global Metabolism Drugs Market Growth 2012-2017, by Type, in USD Million
Figure Global Metabolism Drugs Market Growth 2012-2017, by Type, in Volume
Figure Global Metabolism Drugs Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Metabolism Drugs Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region